Abiopharma

🔍 Beswick Jeffrey A (Executive)

Company: ENVIRI Corp (NVRI)

Report Date: 2026-05-09

Detailed Transactions and Holdings:

• Acquired 9,779 shares of Common Stock (Direct)
  Date: 2026-05-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 121,837.00 | transaction_form_type: 4
• Sold 4,333 shares of Common Stock at $19.26 per share (Direct)
  Date: 2026-05-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 117,504.00 | transaction_form_type: 4
• Sold 9,779 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 37,042.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Restricted stock units granted under the 2013 Equity and Incentive Compensation Plan represent a contingent right to receive Enviri common stock on a one-for-one basis when the restricted stock units vest. The restricted stock units vest in one-third increments on each of the first three anniversaries of the date of the grant.